Hepatitis A

American Family Physician

Volumn 86, Issue 11, 2012, Pages 1027-1034

  Matheny, Samuel C ^a   Kingery, Joe E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M;

ARTICLE; DIFFERENTIAL DIAGNOSIS; EMPORIATRICS; FECES ANALYSIS; HEADACHE; HEPATITIS A; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INFECTION RISK; INJECTION SITE REACTION; MALAISE; MIXED INFECTION; POST EXPOSURE PROPHYLAXIS; RELAPSE; SINGLE DRUG DOSE; VIRUS TRANSMISSION;

EID: 84870778414     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. Hepatitis A FAQs for health professionals. http://www.cdc.gov/hepatitis/HAV/HAVfaq.htm. Accessed June 1, 2012.
2. Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc. 2006;117:227-237.
3. Workowski KA, Berman S; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010 [published correction appears in MMWR Recomm Rep. 2011;60(1):18]. MMWR Recomm Rep. 2010;59(RR-12):1-110.
4. Sfetcu O, Irvine N, Ngui SL, Emerson C, McCaughey C, Donaghy P. Hepatitis A outbreak predominantly affecting men who have sex with men in Northern Ireland, October 2008 to July 2009. Euro Surveill. 2011;16(9):pii=19808.
5. Nainan OV, Xia G, Vaughan G, Margolis HS. Diagnosis of hepatitis A virus infection: a molecular approach. Clin Microbiol Rev. 2006;19(1):63-79.
6. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999:48(RR-12):1-37.
7. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-7):1-23.
8. Centers for Disease Control and Prevention (CDC). Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007;56(41):1080-1084.
9. Centers for Disease Control and Prevention (CDC). Updated recommendations from the Advisory Committee on Immunization Practices (ACIP) for use of hepatitis A vaccine in close contacts of newly arriving international adoptees. MMWR Morb Mortal Wkly Rep. 2009;58(36):1006-1007.
10. Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18(suppl 1):S71-S74.
11. Gluud LL, Gluud C. Meta-analyses on viral hepatitis. Infect Dis Clin North Am. 2009;23(2):315-330.
12. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med. 1980;302(22):1222-1227.
13. Fiore AE. Hepatitis A transmitted by food. Clin Infect Dis. 2004;38(5):705-715.
14. American Medical Association; American Nurses Association-American Nurses Foundation; Centers for Disease Control and Prevention; Center for Food Safety and Applied Nutrition, Food and Drug Administration. Food Safety and Inspection Service, U.S. Department of Agriculture. Diagnosis and management of foodborne illnesses: a primer for physicians and other health care professionals. MMWR Recomm Rep. 2004;53(RR-4):1-33.
15. Johnston DE. Special considerations in interpreting liver function tests. Am Fam Physician. 1999;59(8):2223-2230.
16. Centers for Disease Control and Prevention (CDC). Positive test results for acute hepatitis A virus infection among persons with no recent history of acute hepatitis-United States, 2002-2004. MMWR Morb Mortal Wkly Rep. 2005;54(18):453-456.
17. Centers for Disease Control and Prevention (CDC). Hepatitis A. In: Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed. Washington, DC: Public Health Foundation; 2012:101-113.
18. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 2010;53(1):15-19.
19. Vogt TM, Wise ME, Bell BP, Finelli L. Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination. J Infect Dis. 2008;197(9):1282-1288.
20. Vento S. Fulminant hepatitis associated with hepatitis A virus super-infection in patients with chronic hepatitis C. J Viral Hepat. 2000;7 (suppl 1):7-8.
21. Coppola N, Genovese D, Pisatoru M, et al. Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection. Clin Infect Dis. 2007;44(9):e73-e77.
22. Beyazit Y, Guven GS, Kekilli M, Koklu S, Yolcu OF, Shorbagi A. Acute pericarditis and renal failure complicating acute hepatitis A infection. South Med J. 2006;99(1):82-84.
23. Venkataravanamma P, Rau AT. Severe thrombocytopenia in association with hepatitis A. Indian Pediatr. 2004;41(11):1178-1179.
24. Shenoy R, Nair S, Kamath N. Thrombocytopenia in hepatitis A-an atypical presentation. J Trop Pediatr. 2004;50(4):241-242.
25. Shroff GR, Badve SV, Joshi AG, Desai DC, Abraham P, Sirsat RA. Acute renal tubular injury with acute hepatitis A infection: is it just a coincidence? Nephrology (Carlton). 2004;9(1):44-46.
26. Fan PC, Chen YC, Tian YC, Chang CH, Fang JT, Yang CW. Acute renal failure associated with acute non-fulminant hepatitis A: a case report and review of literature. Ren Fail. 2009;31(8):756-764.
27. Cuthbert JA. Hepatitis A: old and new [published correction appears in Clin Microbiol Rev. 2001;14(3)642]. Clin Microbiol Rev. 2001;14(1):38-58.
28. Yeung LT, Roberts EA. Current issues in the management of paediatric viral hepatitis. Liver Int. 2010;30(1):5-18.
29. Elinav E, Ben-Dov IZ, Shapira Y, et al. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130(4):1129-1134.
30. Nothdurft HD, Dietrich M, Zuckerman JN, et al. A new accelerated vaccination schedule for rapid protection against hepatitis A and B. Vaccine. 2002;20(7-8):1157-1162.
31. Van Herck K, Van Damme P, Lievens M, Stoffel M. Hepatitis A vaccine: indirect evidence of immune memory 12 years after the primary course. J Med Virol. 2004;72(2):194-196.
32. Günther M, Stark K, Neuhaus R, Reinke P, Schröder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71(3):477-479.
33. Tong MJ, Co RL, Bellak C. Hepatitis A vaccination. West J Med. 1993;158(6):602-605.
34. Quaglio G, Pajusco B, Civitelli P, et al. Immunogenicity, reactogenicity and adherence with hepatitis A vaccination among drug users. Drug Alcohol Depend. 2004;74(1):85-88.
35. Czeschinski PA, Binding N, Witting U. Hepatitis A and hepatitis B vaccinations: immunogenicity of combined vaccine and of simultaneously or separately applied single vaccines. Vaccine. 2000;18(11-12):1074-1080.
36. Winokur PL, Stapleton JT. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis. 1992;14(2):580-586.
37. American Academy of Pediatrics Committee on Infectious Diseases. Hepatitis A vaccine recommendations. Pediatrics. 2007;120(1):189-199.